血糖监测仪（BGM设备）市场规模、份额和成长分析（按产品、应用和地区划分）－产业预测，2026-2033年

预计到 2024 年，血糖监测仪（BGM 设备）市场规模将达到 146.6 亿美元，到 2025 年将达到 158.8 亿美元，到 2033 年将达到 300.5 亿美元，预测期（2026-2033 年）的复合年增长率为 8.3%。

全球血糖监测设备（BGM设备）市场正经历显着成长，这主要得益于糖尿病盛行率的不断上升以及对精准可靠监测解决方案日益增长的需求。包括胰岛素笔和持续血糖监测系统在内的设备技术进步，显着改善了患者的治疗效果和设备功能。医疗保健产业尤其致力于提供这些必要的工具，目前血糖监测设备已被纳入多种医疗保险计划，使患者更容易管理糖尿病。人们对血糖控制重要性以及血糖控制不佳相关风险的认识不断提高，进一步推动了设备的普及。因此，血糖监测设备对于个人有效监测血糖值并及时调整治疗方案至关重要。

血糖仪（BGM设备）市场驱动因素

全球糖尿病患者数量的不断增长是推动血糖监测（BGM）设备市场扩张的主要因素。人口老化以及生活方式和饮食习惯的改变是造成这一增长的主要因素，这些因素导致第1型和第2型糖尿病的发生率上升。这种激增凸显了对有效血糖监测解决方案的迫切需求，以便控制血糖值并预防与疾病相关的潜在併发症。随着越来越多的人希望透过定期监测来维护自身健康，对先进血糖监测（BGM）设备的需求持续显着增长。

血糖仪（BGM设备）市场的限制

先进的血糖监测设备（尤其是连续血糖监测系统）高成本，对许多患者而言构成重大障碍。在缺乏医疗援助和报销的地区，这些技术带来的经济负担阻碍了其普及，尤其是在低收入者中。这种可近性不足导致市场细分程度降低，最终阻碍了血糖监测设备市场的整体成长。价格承受能力的差异进一步凸显了製定更全面的定价策略和支持措施的必要性，以改善患者的可及性并促进这些重要监测工具的更广泛应用。

血糖仪（BGM设备）市场趋势

血糖监测（BGM）设备市场正加速向持续血糖监测（CGM）系统转型，该系统可提供即时血糖值测量，并显着改善糖尿病管理。这些先进设备具有更高的准确性、易用性和人性化的设计，使其成为个人和医疗保健提供者更具吸引力的选择。随着患者寻求更有效管理血糖值的方法，CGM系统在家庭和医疗机构中的应用正在迅速扩展。这一趋势预示着医疗保健解决方案正朝着个人化方向发展，科技在其中发挥关键作用，帮助患者主导自身健康。

目录

介绍

• 调查目标
• 定义
• 市场覆盖范围

调查方法

• 资讯收集
• 二手和一手资料资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

前景
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 抑制因素
  • 任务
• 波特分析

关键市场考察

• 技术分析
• 定价分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

血糖仪（BGM设备）市场依产品分类

• 血糖监测仪
  • 单点血糖仪
  • 连续血糖监测系统
  • 感应器
  • 发送器和接收器
  • 外接显示器
• 血糖监测试纸
• 《采血针》

按应用分類的血糖仪（BGM设备）市场

• 医院和诊所
• 诊断中心
• 家庭环境

按地区分類的血糖仪（BGM设备）市场

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲（MEA）
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市占率（2025 年）

主要企业简介

• Abbott（US）
• Medtronic plc（Ireland）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Dexcom, Inc.（US）
• Sanofi（France）
• Novo Nordisk（Denmark）
• Insulet Corporation（US）
• Ypsomed Holdings（Switzerland）
• Glysens Incorporated
• ARKRAY, Inc.（Japan）
• Bayer AG（Germany）
• AgaMatrix, Inc.（US）
• Trividia Health, Inc.（US）
• MediWise Ltd.（UK）
• DiaMonTech AG（Germany）
• B. Braun Melsungen AG（Germany）
• Sinocare, Inc.（China）
• Nipro Corporation（Japan）
• Menarini Diagnostics（Italy）
• Beurer GmbH（Germany）
• Prodigy Diabetes Care, LLC（US）
• Omron Healthcare, Inc.（Japan）

Blood Glucose Monitoring Devices Market size was valued at USD 14.66 Billion in 2024 and is poised to grow from USD 15.88 Billion in 2025 to USD 30.05 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global market for blood glucose monitoring devices is experiencing significant growth, driven by the escalating incidence of diabetes and the rising demand for precise and dependable monitoring solutions. Technological advancements in devices, including insulin pens and continuous glucose monitoring systems, have improved patient outcomes and device functionality. Notably, the healthcare sector provides accessibility to these essential tools, as glucose monitoring devices are covered under various health insurance plans, facilitating patient management of diabetes. Increased awareness of the critical need for glycemic control and the risks associated with unmanaged diabetes is further propelling device adoption. Consequently, blood glucose meters are becoming vital for individuals to monitor their blood sugar levels effectively, ensuring timely adjustments in their treatment regimens.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Monitoring Devices Market Segments Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Blood Glucose Monitoring Devices Market

The increasing prevalence of diabetes globally serves as a key catalyst for the expansion of the blood glucose monitoring devices market. Factors contributing to this rise include an aging population, along with shifts in lifestyle and eating habits, which have led to higher incidences of both type 1 and type 2 diabetes. This upsurge underscores the urgent need for effective glucose monitoring solutions to manage blood sugar levels, thereby preventing potential complications associated with the condition. As more individuals seek to maintain their health through regular monitoring, the demand for advanced blood glucose monitoring devices continues to grow significantly.

Restraints in the Blood Glucose Monitoring Devices Market

The high cost of advanced blood glucose monitoring devices, particularly continuous glucose monitoring systems, poses a significant barrier to accessibility for many patients. In areas lacking healthcare subsidies or reimbursement options, the financial burden associated with these technologies restricts their adoption, particularly among low-income populations. This limited accessibility results in a reduced market segment, ultimately stunting the overall growth of the blood glucose monitoring devices market. The disparity in affordability further emphasizes the need for more inclusive pricing strategies and support initiatives to enhance patient access and drive wider acceptance of these essential monitoring tools.

Market Trends of the Blood Glucose Monitoring Devices Market

The Blood Glucose Monitoring Devices market is increasingly witnessing a shift towards Continuous Glucose Monitoring (CGM) systems, which offer real-time glucose readings and significantly improve diabetes management. These advanced devices enhance accuracy, usability, and user-friendly designs, making them more appealing to both individuals and healthcare providers. As patients seek more efficient ways to monitor their glucose levels, the adoption of CGM systems is proliferating in both home settings and clinical institutions. This trend is indicative of a broader movement towards personalized healthcare solutions, where technology plays a critical role in empowering patients to take control of their health.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Blood Glucose Monitoring Devices Market by Product

• Market Overview
• Blood Glucose Monitors
  • Single Point Blood Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitter and Receivers
  • External Monitor
• Glucose Monitoring Strips
• Lancets

Blood Glucose Monitoring Devices Market by Application

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Home Settings

Blood Glucose Monitoring Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holdings (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glysens Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MediWise Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaMonTech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments